Insider · CIK 0001978041
Alka Batycky
Files at LABP (Landos Biopharma, Inc.). First filing -, latest -.
In brief
Alka Batycky files SEC Form 4 as director at LABP (Landos Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alka Batycky has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 23, 2024 | LABP Landos Biopharma, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -3,600 | - | - | 0 | May 23, 2024 |
Questions about Alka Batycky
Answered from the filings on this page, as of the latest one.
Is Alka Batycky buying or selling?
Alka Batycky has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alka Batycky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alka Batycky has 0.
Where does Alka Batycky file Form 4?
Alka Batycky has filed Form 4 at LABP (Landos Biopharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.